AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Corcept Therapeutics Announces Resignation of President Sean Maduck
PUBLIC · CORTSep 23, 2026•about 4 hours ago
Position
President
Company
Corcept
Sean Maduck
Menlo ParkBiotechnologyHealth CareMedicalTherapeuticsBiotechnology Research
Description
On September 22, 2026, Sean Maduck, the President of Corcept Endocrinology, announced his resignation effective October 1, 2026. The company expressed gratitude for his significant contributions and dedication to patients. Mr
Company Information
Company
Corcept
Location
Menlo Park, California, United States
About
Leading the field in the discovery of drugs that modulate the effects of cortisol.
The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
Fundz sees it the moment Corcept changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.